Medication info
Dangsikajung 10mg (Dapagliflozin Propanediol Hydrate)

Dangsikajung 10mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Korea Hyutex Pharmaceutical Co., Ltd.
Appearance
Yellow, double-sided, convex, diamond-shaped film-coated tablet
Packaging
28 tablets/bottle, 28 tablets/box [7 tablets/Alu-Alu x 4], 30 tablets/bottle
Approval status
Active

MFDS item code 202203132 · Approved 2022.07.29 · Insurance code 649105620

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, including insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacologic treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Korea Hyutex Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is used to assist in the control of blood sugar levels in patients with type 2 diabetes. It is primarily used alone or in combination with dietary management and exercise, and can also be administered when blood sugar is not well controlled. Particularly in patients with cardiovascular diseases or risk factors, it may help in preventing cardiovascular events, so it is advisable to consult a healthcare professional for further information. This medication is used to improve blood sugar control and help manage diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, including insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacologic treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in people who are allergic to the active ingredient or additives, in patients with type 1 diabetes, and in patients undergoing dialysis. Caution is required when using this medication in patients with low fluid volume or renal function issues. This medication can cause low blood pressure or temporary deterioration of kidney function, so fluid status and kidney function should be carefully monitored before and after administration. For patients with moderate to severe renal impairment, the effectiveness in controlling blood sugar may be reduced; therefore, it is not recommended for patients with severely reduced kidney function. While taking this medication, side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, diabetic ketoacidosis, and changes in kidney function may occur, so immediate consultation with a physician is advisable if symptoms arise. Particularly in the elderly, patients with weak kidney function, or those taking diuretics, caution is warranted due to the increased risk of decreased fluid volume and low blood pressure. It is advisable for pregnant or breastfeeding women to avoid using this medication, and to stop taking it immediately if pregnancy is confirmed. This medication can increase the risk of hypoglycemia when used in conjunction with insulin or sulfonylureas, so dosage adjustments for these medications may be needed. During treatment, it is important to regularly monitor fluid volume status, blood sugar, and kidney function and to inform healthcare providers immediately if any abnormal symptoms appear. Additionally, the safety and efficacy of this medication in children have not been established, so it should not be used in this population. In case of overdose, there is no specific antidote; appropriate treatment should be provided based on symptoms, and assistance from healthcare providers may be required. Finally, this medication should be stored in its original container and kept out of reach of children, and it is safest not to change the container.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, dry mouth, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, decreased renal creatinine clearance in early treatment, dyslipidemia, elevated serum creatinine in early treatment, increased blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic liver cirrhosis, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyps, bowel perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency incontinence, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitation, urolithiasis, abnormal urination, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste disturbances, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, coma, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, hordeolum, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, breast mass, erectile dysfunction, benign prostatic hyperplasia, mastalgia, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, itching, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, preferably at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Yellow, double-sided, convex, diamond-shaped film-coated tablet

Package unit

28 tablets/bottle, 28 tablets/box [7 tablets/Alu-Alu x 4], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.